Join us at the Symposium where we will explore the practical and research applications of biomarkers within the Amyotrophic Lateral Sclerosis (ALS) and motor neuron diseases community.
Damien Eggenspieler, our Healthcare Program Director will moderate a session on the utilisation of biomarkers, shedding light on the role digital health can play in improving clinical research in ALS.
We are eager to connect with you at the conference!
Save the date: November 29th, 2023
Can a single wearable platform derive meaningful clinical conclusions across 10+ neurological diseases? The evidence says yes.We’re presenting three new posters at EAN 2025, each
As the development of innovative therapies for ALS accelerates around the world, the need for objective and clinically meaningful measures of disease progression has never
We’re attending the 15th International Myotonic Dystrophy Consortium Meeting, taking place May 26–30, 2026 in Saguenay, Québec, Canada. This year, we’re presenting real-world data from
